- Home
- Publications
- Publication Search
- Publication Details
Title
Antitumor Drugs and Their Targets
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 23, Pages 5776
Publisher
MDPI AG
Online
2020-12-11
DOI
10.3390/molecules25235776
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Foretinib Inhibits Cancer Stemness and Gastric Cancer Cell Proliferation by Decreasing CD44 and c-MET Signaling
- (2020) Sung-Hwa Sohn et al. OncoTargets and Therapy
- Anti-Inflammatory Drugs as Anticancer Agents
- (2020) Silvia Zappavigna et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Regulation of aerobic glycolysis to decelerate tumor proliferation by small molecule inhibitors targeting glucose transporters
- (2020) Meng Gao et al. Protein & Cell
- Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
- (2020) Courtney D. DiNardo et al. NEW ENGLAND JOURNAL OF MEDICINE
- cGAS-STING pathway in oncogenesis and cancer therapeutics
- (2020) Brandon Yi Da Hoong et al. Oncotarget
- Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy
- (2020) Juyan Zheng et al. Molecular Cancer
- Enhancing anti-tumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors
- (2019) K M Heinhuis et al. ANNALS OF ONCOLOGY
- Revisiting Telomere Shortening in Cancer
- (2019) Keiji Okamoto et al. Cells
- Anti-tumor drug targets analysis: current insight and future prospect
- (2019) Sheng Wang et al. CURRENT DRUG TARGETS
- Telomerase-Targeted Cancer Immunotherapy
- (2019) Eishiro Mizukoshi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Direct Ras G12C inhibitors: crossing the rubicon
- (2019) Colin R. Lindsay et al. BRITISH JOURNAL OF CANCER
- On Integrity in Immunity During Ontogeny or How Thymic Regulatory T Cells Work
- (2019) Zlatko Dembic SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- The Mutator Phenotype: Adapting Microbial Evolution to Cancer Biology
- (2019) Federica Natali et al. Frontiers in Genetics
- Invasion and metastasis: the elusive hallmark of cancer
- (2019) Tomer Meirson et al. ONCOGENE
- Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update
- (2019) Joseph A. Clara et al. Nature Reviews Clinical Oncology
- Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
- (2018) Matthew R. Janes et al. CELL
- Overview on Anticancer Drug Design and Development
- (2018) Sureyya Olgen CURRENT MEDICINAL CHEMISTRY
- Promising Targets in Anti-cancer Drug Development: Recent Updates
- (2018) Bhupinder Kumar et al. CURRENT MEDICINAL CHEMISTRY
- Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator’s Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial
- (2018) James Larkin et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- (2018) Alexandra K. Rzepecki et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Asparagine bioavailability governs metastasis in a model of breast cancer
- (2018) Simon R. V. Knott et al. NATURE
- The Guardian of the Genome Revisited: p53 Downregulates Genes Required for Telomere Maintenance, DNA Repair, and Centromere Structure
- (2018) Eléonore Toufektchan et al. Cancers
- DNA repair pathways and cisplatin resistance: an intimate relationship
- (2018) CR Rocha et al. Clinics
- Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
- (2018) Luca Falzone et al. Frontiers in Pharmacology
- FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease
- (2018) Emily Y. Jen et al. CLINICAL CANCER RESEARCH
- Radiation fractionation: the search for isoeffect relationships and mechanisms
- (2017) John E. Moulder et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Metastasis suppressors: functional pathways
- (2017) Imran Khan et al. LABORATORY INVESTIGATION
- Telomeres in cancer: tumour suppression and genome instability
- (2017) John Maciejowski et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Epigenetic plasticity and the hallmarks of cancer
- (2017) William A. Flavahan et al. SCIENCE
- Differences between germline and somatic mutation rates in humans and mice
- (2017) Brandon Milholland et al. Nature Communications
- Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies
- (2017) Emmet J. Jordan et al. Cancer Discovery
- Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs)
- (2017) Ernestina Marianna De Francesco et al. Oncotarget
- Cohesin mutations in human cancer
- (2016) Victoria K. Hill et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
- (2016) Gary Middleton et al. BRITISH JOURNAL OF CANCER
- Human Cancers Express a Mutator Phenotype: Hypothesis, Origin, and Consequences
- (2016) Lawrence A. Loeb CANCER RESEARCH
- Targeting BCL2 With BH3 Mimetics: Basic Science and Clinical Application of Venetoclax in Chronic Lymphocytic Leukemia and Related B Cell Malignancies
- (2016) AW Roberts et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Mouse models of DNA mismatch repair in cancer research
- (2016) Kyeryoung Lee et al. DNA REPAIR
- Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
- (2016) V.R. Belum et al. EUROPEAN JOURNAL OF CANCER
- Cancer chemoresistance; biochemical and molecular aspects: a brief overview
- (2016) Saeed Kachalaki et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Evolution of Mutation Rates in Rapidly Adapting Asexual Populations
- (2016) B. H. Good et al. GENETICS
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
- (2016) Joshua D Campbell et al. NATURE GENETICS
- Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
- (2016) Marios Giannakis et al. Cell Reports
- Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
- (2016) Mohammad A. Jafri et al. Genome Medicine
- Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation
- (2016) Lisa Deloch et al. Frontiers in Oncology
- Inhibition of the ERCC1–XPF structure-specific endonuclease to overcome cancer chemoresistance
- (2015) Ewan M. McNeil et al. DNA REPAIR
- Mismatch Repair
- (2015) Richard Fishel JOURNAL OF BIOLOGICAL CHEMISTRY
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Evolutionary Determinants of Cancer
- (2015) M. Greaves Cancer Discovery
- The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo
- (2015) Frank P. Vendetti et al. Oncotarget
- The p53 Isoform Δ133p53β Promotes Cancer Stem Cell Potential
- (2015) Nikola Arsic et al. Stem Cell Reports
- Oligonucleotides and G-quadruplex Stabilizers: Targeting Telomeres and Telomerase in Cancer Therapy
- (2014) Zachary Crees et al. CURRENT PHARMACEUTICAL DESIGN
- A Small Molecule Inhibitor of Monoubiquitinated Proliferating Cell Nuclear Antigen(PCNA) Inhibits Repair of Interstrand DNA Cross-link, Enhances DNA Double Strand Break, and Sensitizes Cancer Cells to Cisplatin
- (2014) Akira Inoue et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
- (2014) Gary Middleton et al. LANCET ONCOLOGY
- Oxygen sensing and metabolic homeostasis
- (2014) Biff F. Palmer et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy
- (2014) Nada Albarakati et al. Molecular Oncology
- A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin
- (2014) David A. Alagpulinsa et al. Frontiers in Oncology
- Understanding and targeting cancer stem cells: therapeutic implications and challenges
- (2013) Ke Chen et al. ACTA PHARMACOLOGICA SINICA
- BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
- (2013) Eleni D. Lagadinou et al. Cell Stem Cell
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability
- (2013) Benjamin E. L. Lauffer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The effect of population bottlenecks on mutation rate evolution in asexual populations
- (2013) Y. Raynes et al. JOURNAL OF EVOLUTIONARY BIOLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuit
- (2013) Ka-Kit Mak et al. MOLECULAR NUTRITION & FOOD RESEARCH
- On Recognizing ‘Shades-of-Gray’ (Self-Nonself Discrimination) or ‘Colour’ (Integrity Model) by The Immune System
- (2013) Z. Dembic SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Deciphering Signatures of Mutational Processes Operative in Human Cancer
- (2013) Ludmil B. Alexandrov et al. Cell Reports
- Marginating Dendritic Cells of the Tumor Microenvironment Cross-Present Tumor Antigens and Stably Engage Tumor-Specific T Cells
- (2012) John J. Engelhardt et al. CANCER CELL
- DNA Methylation Screening Identifies Driver Epigenetic Events of Cancer Cell Survival
- (2012) Daniel D. De Carvalho et al. CANCER CELL
- Novel anticancer therapeutics targeting telomerase
- (2012) Maria Ruden et al. CANCER TREATMENT REVIEWS
- Transcriptional Amplification in Tumor Cells with Elevated c-Myc
- (2012) Charles Y. Lin et al. CELL
- Pterostilbene induces mitochondrially derived apoptosis in breast cancer cells in vitro
- (2012) Dora Moon et al. JOURNAL OF SURGICAL RESEARCH
- The promise of induced pluripotent stem cells in research and therapy
- (2012) Daisy A. Robinton et al. NATURE
- Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers
- (2012) Anna Krzeslak et al. PATHOLOGY & ONCOLOGY RESEARCH
- Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes
- (2011) Christopher M. Heaphy et al. AMERICAN JOURNAL OF PATHOLOGY
- The contribution of Marie Skłodowska-Curie to the development of modern oncology
- (2011) Andrzej Kułakowski ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer
- (2011) J. Krempski et al. JOURNAL OF IMMUNOLOGY
- Novel Irreversible Small Molecule Inhibitors of Replication Protein A Display Single-Agent Activity and Synergize with Cisplatin
- (2011) T. M. Neher et al. MOLECULAR CANCER THERAPEUTICS
- Bone marrow-derived mesenchymal stem cells and the tumor microenvironment
- (2010) Scott A. Bergfeld et al. CANCER AND METASTASIS REVIEWS
- A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs
- (2010) Jonghwan Kim et al. CELL
- Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues
- (2010) Jacob H. Hanna et al. CELL
- Therapeutic Targeting of the DNA Mismatch Repair Pathway
- (2010) S. A. Martin et al. CLINICAL CANCER RESEARCH
- Sipuleucel-T
- (2010) Greg L. Plosker DRUGS
- Mechanisms of resistance to antiangiogenesis therapy
- (2010) Faisal Azam et al. EUROPEAN JOURNAL OF CANCER
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Alternative lengthening of telomeres: models, mechanisms and implications
- (2010) Anthony J. Cesare et al. NATURE REVIEWS GENETICS
- GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis
- (2009) Thomas Amann et al. AMERICAN JOURNAL OF PATHOLOGY
- Telomere and Telomerase as Targets for Cancer Therapy
- (2009) Xiaoping Tian et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Dynamics of telomerase activity in response to acute psychological stress
- (2009) Elissa S. Epel et al. BRAIN BEHAVIOR AND IMMUNITY
- Targeting the PI3K signaling pathway in cancer
- (2009) Kwok-Kin Wong et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy
- (2008) L. Hambach et al. BLOOD
- Recent advances in cancer stem cells
- (2008) Robert W Cho et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Recent Advances in Cancer Vaccines: An Overview
- (2008) K. Itoh et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel
- (2008) T. M. Sissung et al. MOLECULAR CANCER THERAPEUTICS
- Ras oncogenes: split personalities
- (2008) Antoine E. Karnoub et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Isolation and Molecular Characterization of Cancer Stem Cells in MMTV-Wnt-1Murine Breast Tumors
- (2007) Robert W. Cho et al. STEM CELLS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started